tiprankstipranks
Trending News
More News >
Beta Bionics, Inc. (BBNX)
NASDAQ:BBNX
US Market

Beta Bionics, Inc. (BBNX) Financial Statements

Compare
49 Followers

Beta Bionics, Inc. Financial Overview

Beta Bionics, Inc.'s market cap is currently $777.03M. The company's EPS TTM is $-0.33; its P/E ratio is -9.64; Beta Bionics, Inc. is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 65.12M$ 11.99M$ 179.00K
Gross Profit$ 35.89M$ 6.31M$ 179.00K
Operating Income$ -45.25M$ -35.85M$ -65.84M
EBITDA$ -44.10M$ -34.62M$ -63.40M
Net Income$ -54.76M$ -44.10M$ -64.75M
Balance Sheet
Cash & Short-Term Investments$ 103.58M$ 96.75M$ 27.68M
Total Assets$ 149.65M$ 110.04M$ 35.53M
Total Debt$ 7.25M$ 4.22M$ 4.13M
Net Debt$ -23.18M$ -22.34M$ -23.54M
Total Liabilities$ 73.63M$ 51.43M$ 22.53M
Stockholders' Equity$ 76.01M$ 58.61M$ 13.00M
Cash Flow
Free Cash Flow$ -51.67M$ -32.85M$ -60.98M
Operating Cash Flow$ -48.27M$ -32.45M$ -60.21M
Investing Cash Flow$ -3.48M$ -69.69M$ -769.00K
Financing Cash Flow$ 55.62M$ 101.03M$ 56.78M
Currency in USD

Beta Bionics, Inc. Earnings and Revenue History

Beta Bionics, Inc. Debt to Assets

Beta Bionics, Inc. Cash Flow

Beta Bionics, Inc. Forecast EPS vs Actual EPS